Efficacy and Safety Study of Bepotastine Besilate Ophthalmic Solution in Allergic Conjunctivitis

Completed · Phase 3 · Has a placebo group

Conditions studied: Allergic Conjunctivitis

In brief

Efficacy and safety study of bepotastine besilate ophthalmic solution in allergic conjunctivitis

Key facts

Study ID

NCT00586664

Run by

Bausch & Lomb Incorporated

People needed

130

Starts

2007-10-01

Expected to finish

2008-06-01

Last updated by the study team

2013-02-08

Who can join

Age: 10 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects must be at least 10 years of age

You may not qualify if…

• No active ocular disease

Where it is running

• ISTA Pharmaceuticals, Inc. — Irvine, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.